Editorial
Interventional oncology: aiming globally to be the 4th pillar of cancer care
Chinese Clinical Oncology
2019;
8
(6)
:56
.
(27 December 2019)
Review Article
Role of image-guided biopsy and radiomics in the age of precision medicine
Chinese Clinical Oncology
2019;
8
(6)
:57
.
(27 December 2019)
Thermal ablation for hepatocellular carcinoma: what’s new in 2019
Chinese Clinical Oncology
2019;
8
(6)
:58
.
(27 December 2019)
Applications of transcatheter embolotherapy in preparation for liver transplantation and resection
Chinese Clinical Oncology
2019;
8
(6)
:59
.
(27 December 2019)
Embolotherapy of unresectable hepatocellular carcinoma: Eastern perspective
Chinese Clinical Oncology
2019;
8
(6)
:60
.
(27 December 2019)
Needle-guided ablation of locally advanced pancreatic cancer: cytoreduction or immunomodulation by in vivo vaccination?
Chinese Clinical Oncology
2019;
8
(6)
:61
.
(27 December 2019)
Percutaneous management of metastatic osseous disease
Chinese Clinical Oncology
2019;
8
(6)
:62
.
(27 December 2019)
Renal ablation: current management strategies and controversies
Chinese Clinical Oncology
2019;
8
(6)
:63
.
(27 December 2019)
Editorial Commentary
Advances in percutaneous lung tumor therapy: 2019 update
Chinese Clinical Oncology
2019;
8
(6)
:64
.
(27 December 2019)
New technological advancements for interventional oncology
Chinese Clinical Oncology
2019;
8
(6)
:65
.
(27 December 2019)
Review Article
Percutaneous palliative care interventions in the cancer patient
Chinese Clinical Oncology
2019;
8
(6)
:66
.
(27 December 2019)
Disclosure:
The focused issue “Interventional Oncology” was commissioned by the Editorial office, Chinese Clinical Oncology without any sponsorship or funding. David C. Madoff, Julius Chapiro and Uei Pua served as the unpaid Guest Editors for the focused issue.
